Asthma Trials in Genoa, Italy
Conditions / Asthma / Genoa, Italy
Asthma has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01842607 | A Study to Determine Long-term Safety of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 |
| NCT06676319 | Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma | RECRUITING | — |
| NCT01691521 | Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma | COMPLETED | PHASE3 |
| NCT01475032 | Efficacy Study of the Product CHF 1535 Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children | COMPLETED | PHASE3 |
| NCT06932263 | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids | RECRUITING | PHASE2 |
| NCT02537691 | Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers | COMPLETED | PHASE4 |
| NCT06100042 | Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting | ACTIVE_NOT_RECRUITING | — |
| NCT06529419 | A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations | COMPLETED | PHASE2 |
| NCT02135692 | A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects | COMPLETED | PHASE3 |
| NCT01499446 | A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma. | COMPLETED | PHASE2 |